Research Overview
What each active brings
GHK-Cu carries the matrix-side literature: fibroblast responses, collagen and glycosaminoglycan production, metalloproteinase and TIMP balance, and antioxidant chemistry that depends on the coordinated copper. Niacinamide carries a keratinocyte and barrier-side literature: ceramide and barrier-lipid synthesis, differentiation markers, sebum and pigment-transfer endpoints, and its position upstream of NAD in cellular metabolism.
Why the pairing is studied
Combination designs test whether dermal and epidermal endpoints move together, whether niacinamide alters barrier properties in a way that changes delivery of the peptide complex, and whether either active is compromised by the presence of the other. The answers are formulation-specific, which is why single-active control arms in the same base are essential to any meaningful comparison.
Formulation chemistry to watch
Niacinamide is typically included at percentages an order of magnitude above peptide actives and is sensitive to pH: under acidic or hot conditions it hydrolyses to nicotinic acid. Copper complexes have their own pH and ligand sensitivities. Finding a window that keeps both intact is a real formulation constraint, and stability programmes should assay each active separately rather than inferring one from the other.
Typical endpoints
Reconstructed epidermis and skin explant models supply barrier-function readouts such as transepidermal water loss analogues and lipid profiling for the niacinamide component, while matrix markers and fibroblast assays address the GHK-Cu component. Diffusion-cell work measures each active independently to check for co-penetration effects.
Matched comparators
Our GHK-Cu cream uses the same peptide specification in a comparable emollient base, which makes it the natural single-active control for isolating what the niacinamide addition contributes.